Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-Blocker in Acute Ischemic Stroke – early propranolol treatment
2008-007031-41Phase 2Terminated
- Sponsor
- Center for Stroke Research Berlin
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke and brain infarction comparing Propranolol arm with Placebo arm (2 arms). Primary endpoint: Cardiovascular and neurological complications including vascular death within 30 days. Started Sep 2009; status: terminated.
02
Drugs
propranolol
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on 2008-007031-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007031-41.